Literature DB >> 28292234

Bovine Serum Albumin as a Versatile Platform for Cancer Imaging and Therapy.

Jun Wang1, Bingbo Zhang1.   

Abstract

BACKGROUND: Due to the good biocompatibility, biodegradability, facile surface functionalization and high water solubility, Bovine serum albumin has gain increasing attention in the nanomedicine.
OBJECTIVE: Despite there are many reviews on albumin based nanoparticles, most of them focus on one aspect of the albumin functionality, e.g., drug delivery, cancer theranostics or half-life extension in vivo. This review aims to comprehensively summary bovine serum albumin as a versatile platform in the applications of cancer imaging and therapy.
METHODS: We review the extensive applications of bovine serum albumin in drug carrier, surface engineering and biomimetic synthesis for cancer imaging and therapy.
CONCLUSION: Based on the studies reviewed, variety of in vitro and in vivo studies show good performance of bovine serum albumin as the drug carrier, surface modification agent and biomimetic template in cancer imaging and therapy. Nevertheless, there are still some issues to be solved, e.g., the technological parameters for enhancing the drug loading efficiency and controlling drug release, optimizing surface modification process to provide more stable nanoagents, investigation of the biomimetic mechanism, in-depth study of their toxicity, further exploring their bioapplications, etc. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  BSA; Nanotheranostics; bio-mimetic nanoparticles; cancer imagingzzm321990and therapy; drug carrier; surface modification.

Mesh:

Substances:

Year:  2018        PMID: 28292234     DOI: 10.2174/0929867324666170314143335

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  3 in total

1.  Preparation and Evaluation of Cabazitaxel-Loaded Bovine Serum Albumin Nanoparticles for Prostate Cancer.

Authors:  Zhong Wan; Fangyuan Xie; Liang Wang; Guoqing Zhang; Hai Zhang
Journal:  Int J Nanomedicine       Date:  2020-07-29

2.  RNA m6A Alterations Induced by Biomineralization Nanoparticles: A Proof-of-Concept Study of Epitranscriptomics for Nanotoxicity Evaluation.

Authors:  Jinbin Pan; Jiaojiao Wang; Kun Fang; Wenjing Hou; Bing Li; Jie Zhao; Xinlong Ma
Journal:  Nanoscale Res Lett       Date:  2022-02-05       Impact factor: 5.418

3.  Development of S4A-BSA-Au NPs for enhanced anti-tumor therapy of canine breast cancer.

Authors:  Qi Chen; Chengfang Xu; Zhonghao Sun; Jingjing Yang; Fan Chen; Zixiang Lin; Degui Lin; Yanyan Jiang; Jiahao Lin
Journal:  Nanoscale Adv       Date:  2021-10-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.